Atopic Dermatitis Clinical Trial
Official title:
Probiotics and Breastmilk Are Associated With a Decreased Risk of Atopic Dermatitis in Very Low Birth Weight Premature Infants
Verified date | September 2023 |
Source | Hospital Clinico Universitario San Cecilio |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The purpose of this study is assess if the use of probiotic in very low weight could be other benefits a long time, as reduce atopic disease in this children.
Status | Completed |
Enrollment | 437 |
Est. completion date | March 2022 |
Est. primary completion date | December 31, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A to 32 Weeks |
Eligibility | Inclusion Criteria: - Newborn with a gestational age < or = 32 weeks and/or birth weight < or = 1500 grams. Exclusion Criteria: - Incomplete health history record o lack of data. - Severe congenital anomalies. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
José Uberos Fernández |
Altobelli E, Angeletti PM, Verrotti A, Petrocelli R. The Impact of Human Milk on Necrotizing Enterocolitis: A Systematic Review and Meta-Analysis. Nutrients. 2020 May 6;12(5):1322. doi: 10.3390/nu12051322. — View Citation
Bjorkander S, Carvalho-Queiroz C, Hallberg J, Persson JO, Johansson MA, Nussbaum B, Jenmalm MC, Nilsson C, Sverremark-Ekstrom E. Childhood allergy is preceded by an absence of gut lactobacilli species and higher levels of atopy-related plasma chemokines. Clin Exp Immunol. 2020 Dec;202(3):288-299. doi: 10.1111/cei.13494. Epub 2020 Aug 5. — View Citation
Campos-Martinez AM, Exposito-Herrera J, Gonzalez-Bolivar M, Fernandez-Marin E, Uberos J. Evaluation of Risk and Preventive Factors for Necrotizing Enterocolitis in Premature Newborns. A Systematic Review of the Literature. Front Pediatr. 2022 May 17;10:874976. doi: 10.3389/fped.2022.874976. eCollection 2022. — View Citation
Cukrowska B, Ceregra A, Maciorkowska E, Surowska B, Zegadlo-Mylik MA, Konopka E, Trojanowska I, Zakrzewska M, Bierla JB, Zakrzewski M, Kanarek E, Motyl I. The Effectiveness of Probiotic Lactobacillus rhamnosus and Lactobacillus casei Strains in Children with Atopic Dermatitis and Cow's Milk Protein Allergy: A Multicenter, Randomized, Double Blind, Placebo Controlled Study. Nutrients. 2021 Apr 1;13(4):1169. doi: 10.3390/nu13041169. — View Citation
Cuna A, Morowitz MJ, Ahmed I, Umar S, Sampath V. Dynamics of the preterm gut microbiome in health and disease. Am J Physiol Gastrointest Liver Physiol. 2021 Apr 1;320(4):G411-G419. doi: 10.1152/ajpgi.00399.2020. Epub 2021 Jan 13. — View Citation
Damm JA, Smith B, Greisen G, Krogfelt KA, Clausen ML, Agner T. The influence of probiotics for preterm neonates on the incidence of atopic dermatitis-results from a historically controlled cohort study. Arch Dermatol Res. 2017 May;309(4):259-264. doi: 10.1007/s00403-017-1725-4. Epub 2017 Mar 7. — View Citation
David TJ, Ewing CI. Atopic eczema and preterm birth. Arch Dis Child. 1988 Apr;63(4):435-6. doi: 10.1136/adc.63.4.435. — View Citation
Fanfaret IS, Boda D, Ion LM, Hosseyni D, Leru P, Ali S, Corcea S, Bumbacea R. Probiotics and prebiotics in atopic dermatitis: Pros and cons (Review). Exp Ther Med. 2021 Dec;22(6):1376. doi: 10.3892/etm.2021.10811. Epub 2021 Sep 28. — View Citation
Fenton TR, Kim JH. A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr. 2013 Apr 20;13:59. doi: 10.1186/1471-2431-13-59. — View Citation
Fijan S, Kolc N, Hrasovec M, Jamtvedt G, Pogacar MS, Micetic Turk D, Maver U. Single-Strain Probiotic Lactobacilli for the Treatment of Atopic Dermatitis in Children: A Systematic Review and Meta-Analysis. Pharmaceutics. 2023 Apr 17;15(4):1256. doi: 10.3390/pharmaceutics15041256. — View Citation
Fuleihan RL. The hygiene hypothesis and atopic disease. Curr Opin Pediatr. 2002 Dec;14(6):676-7. doi: 10.1097/00008480-200212000-00004. No abstract available. — View Citation
Gdalevich M, Mimouni D, David M, Mimouni M. Breast-feeding and the onset of atopic dermatitis in childhood: a systematic review and meta-analysis of prospective studies. J Am Acad Dermatol. 2001 Oct;45(4):520-7. doi: 10.1067/mjd.2001.114741. — View Citation
Hahn WH, Kim J, Song S, Park S, Kang NM. The human milk oligosaccharides are not affected by pasteurization and freeze-drying. J Matern Fetal Neonatal Med. 2019 Mar;32(6):985-991. doi: 10.1080/14767058.2017.1397122. Epub 2017 Nov 6. — View Citation
Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet. 2001 Apr 7;357(9262):1076-9. doi: 10.1016/S0140-6736(00)04259-8. — View Citation
Levine TA, Grunau RE, McAuliffe FM, Pinnamaneni R, Foran A, Alderdice FA. Early childhood neurodevelopment after intrauterine growth restriction: a systematic review. Pediatrics. 2015 Jan;135(1):126-41. doi: 10.1542/peds.2014-1143. — View Citation
Lima PA, Carvalho Md, Costa AC, Moreira ME. Variables associated with extra uterine growth restriction in very low birth weight infants. J Pediatr (Rio J). 2014 Jan-Feb;90(1):22-7. doi: 10.1016/j.jped.2013.05.007. Epub 2013 Oct 22. — View Citation
Martinez FD, Guerra S. Early Origins of Asthma. Role of Microbial Dysbiosis and Metabolic Dysfunction. Am J Respir Crit Care Med. 2018 Mar 1;197(5):573-579. doi: 10.1164/rccm.201706-1091PP. No abstract available. — View Citation
Nagasaki T, Tabuchi T, Matsumoto H, Horimukai K. Age-specific associations of early daycare, older siblings, severe airway infection, and preterm birth with subsequent atopic diseases. Pediatr Allergy Immunol. 2022 Apr;33(4):e13771. doi: 10.1111/pai.13771. — View Citation
Narbona Lopez E, Uberos Fernandez J, Armada Maresca MI, Couce Pico ML, Rodriguez Martinez G, Saenz de Pipaon M. [Nutrition and Metabolism Group of the Spanish Neonatology Society: recommendations and evidence for dietary supplementation with probiotics in very low birth weight infants]. An Pediatr (Barc). 2014 Dec;81(6):397.e1-8. doi: 10.1016/j.anpedi.2014.06.020. Epub 2014 Aug 6. Spanish. — View Citation
Niele N, van Zwol A, Westerbeek EA, Lafeber HN, van Elburg RM. Effect of non-human neutral and acidic oligosaccharides on allergic and infectious diseases in preterm infants. Eur J Pediatr. 2013 Mar;172(3):317-23. doi: 10.1007/s00431-012-1886-2. Epub 2012 Nov 7. — View Citation
Nolan LS, Rimer JM, Good M. The Role of Human Milk Oligosaccharides and Probiotics on the Neonatal Microbiome and Risk of Necrotizing Enterocolitis: A Narrative Review. Nutrients. 2020 Oct 6;12(10):3052. doi: 10.3390/nu12103052. — View Citation
Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab. 2015;66 Suppl 1:8-16. doi: 10.1159/000370220. Epub 2015 Apr 24. — View Citation
Olesen AB, Ellingsen AR, Olesen H, Juul S, Thestrup-Pedersen K. Atopic dermatitis and birth factors: historical follow up by record linkage. BMJ. 1997 Apr 5;314(7086):1003-8. doi: 10.1136/bmj.314.7086.1003. — View Citation
Olsen R, Greisen G, Schroder M, Brok J. Prophylactic Probiotics for Preterm Infants: A Systematic Review and Meta-Analysis of Observational Studies. Neonatology. 2016;109(2):105-12. doi: 10.1159/000441274. Epub 2015 Dec 2. — View Citation
Panduru M, Salavastru CM, Panduru NM, Tiplica GS. Birth weight and atopic dermatitis: systematic review and meta-analyis. Acta Dermatovenerol Croat. 2014;22(2):91-6. — View Citation
Pincus M, Keil T, Rucke M, Bruenahl C, Magdorf K, Klapp BF, Douglas AJ, Paus R, Wahn U, Arck P. Fetal origin of atopic dermatitis. J Allergy Clin Immunol. 2010 Jan;125(1):273-5.e1-4. doi: 10.1016/j.jaci.2009.10.057. No abstract available. — View Citation
Plummer EL, Chebar Lozinsky A, Tobin JM, Uebergang JB, Axelrad C, Garland SM, Jacobs SE, Tang MLK; ProPrems Study Group. Postnatal probiotics and allergic disease in very preterm infants: Sub-study to the ProPrems randomized trial. Allergy. 2020 Jan;75(1):127-136. doi: 10.1111/all.14088. Epub 2019 Nov 8. — View Citation
Rudzki E, Samochocki Z, Rebandel P, Saciuk E, Galecki W, Raczka A, Szmurlo A. Frequency and significance of the major and minor features of Hanifin and Rajka among patients with atopic dermatitis. Dermatology. 1994;189(1):41-6. doi: 10.1159/000246781. — View Citation
Rzehak P, Wijga AH, Keil T, Eller E, Bindslev-Jensen C, Smit HA, Weyler J, Dom S, Sunyer J, Mendez M, Torrent M, Vall O, Bauer CP, Berdel D, Schaaf B, Chen CM, Bergstrom A, Fantini MP, Mommers M, Wahn U, Lau S, Heinrich J; GA(2)LEN-WP 1.5 Birth Cohorts. Body mass index trajectory classes and incident asthma in childhood: results from 8 European Birth Cohorts--a Global Allergy and Asthma European Network initiative. J Allergy Clin Immunol. 2013 Jun;131(6):1528-36. doi: 10.1016/j.jaci.2013.01.001. Epub 2013 Feb 10. — View Citation
Samuels N, van de Graaf R, Been JV, de Jonge RC, Hanff LM, Wijnen RM, Kornelisse RF, Reiss IK, Vermeulen MJ. Necrotising enterocolitis and mortality in preterm infants after introduction of probiotics: a quasi-experimental study. Sci Rep. 2016 Aug 22;6:31643. doi: 10.1038/srep31643. — View Citation
Sherman PM, Cabana M, Gibson GR, Koletzko BV, Neu J, Veereman-Wauters G, Ziegler EE, Walker WA. Potential roles and clinical utility of prebiotics in newborns, infants, and children: proceedings from a global prebiotic summit meeting, New York City, June 27-28, 2008. J Pediatr. 2009 Nov;155(5):S61-70. doi: 10.1016/j.jpeds.2009.08.022. Erratum In: J Pediatr. 2010 Feb;156(2):344. — View Citation
Simpson A, Brough HA, Haider S, Belgrave D, Murray CS, Custovic A. Early-life inhalant allergen exposure, filaggrin genotype, and the development of sensitization from infancy to adolescence. J Allergy Clin Immunol. 2020 Mar;145(3):993-1001. doi: 10.1016/j.jaci.2019.08.041. Epub 2019 Oct 17. — View Citation
Steffensen FH, Sorensen HT, Gillman MW, Rothman KJ, Sabroe S, Fischer P, Olsen J. Low birth weight and preterm delivery as risk factors for asthma and atopic dermatitis in young adult males. Epidemiology. 2000 Mar;11(2):185-8. doi: 10.1097/00001648-200003000-00018. — View Citation
Thureen PJ. Early aggressive nutrition in very preterm infants. Nestle Nutr Workshop Ser Pediatr Program. 2007;59:193-204; discussion 204-8. doi: 10.1159/000098536. — View Citation
Trikamjee T, Comberiati P, D'Auria E, Peroni D, Zuccotti GV. Nutritional Factors in the Prevention of Atopic Dermatitis in Children. Front Pediatr. 2021 Jan 12;8:577413. doi: 10.3389/fped.2020.577413. eCollection 2020. — View Citation
Uberos J, Aguilera-Rodriguez E, Jerez-Calero A, Molina-Oya M, Molina-Carballo A, Narbona-Lopez E. Probiotics to prevent necrotising enterocolitis and nosocomial infection in very low birth weight preterm infants. Br J Nutr. 2017 Apr;117(7):994-1000. doi: 10.1017/S0007114517000769. Epub 2017 Apr 26. — View Citation
Uberos J, Campos-Martinez A, Fernandez-Marin E, Millan IC, Lopez AR, Blanca-Jover E. Effectiveness of two probiotics in preventing necrotising enterocolitis in a cohort of very-low-birth-weight premature new-borns. Benef Microbes. 2022 Feb 28;13(1):25-31. doi: 10.3920/BM2021.0088. Epub 2021 Nov 18. — View Citation
Uberos J. Perinatal microbiota: review of its importance in newborn health. Arch Argent Pediatr. 2020 Jun;118(3):e265-e270. doi: 10.5546/aap.2020.eng.e265. English, Spanish. — View Citation
Voigt J, Lele M. Lactobacillus rhamnosus Used in the Perinatal Period for the Prevention of Atopic Dermatitis in Infants: A Systematic Review and Meta-Analysis of Randomized Trials. Am J Clin Dermatol. 2022 Nov;23(6):801-811. doi: 10.1007/s40257-022-00723-x. Epub 2022 Sep 26. — View Citation
Yang YW, Tsai CL, Lu CY. Exclusive breastfeeding and incident atopic dermatitis in childhood: a systematic review and meta-analysis of prospective cohort studies. Br J Dermatol. 2009 Aug;161(2):373-83. doi: 10.1111/j.1365-2133.2009.09049.x. Epub 2009 Feb 23. — View Citation
Zachariassen G. Nutrition, growth, and allergic diseases among very preterm infants after hospital discharge. Dan Med J. 2013 Feb;60(2):B4588. — View Citation
* Note: There are 41 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change incidence of atopic dermatitis in children receiving probiotics | The investigators will assess the presence of atopic dermatitis (itching and chronic or recurrent eczematous lesions with typical morphology and distribution) in the telephone interview. | From birth to January 2023 | |
Primary | To assess whether the combined use of breast milk and probiotics has a beneficial effect on the prevention of atopic dermatitis in children. | The investigators will ask patients for both attopic dermatitis involvement and a history of probiotic and breast milk administration in the neonatal period. | From birth to January 2023 | |
Primary | Identify probiotic strains that may decrease the incidence of atopic dermatitis. | In the group of patients who received probiotics we found two groups, one group received Lacticaseibacillus rhamnosus ATCC 53103 and the other group received the combination of Lactobacillus acidophilus ATCC 4356 + Bifidobacterium bifidum ATCC 15696. An attempt will be made to identify if there are differences between them. | From birth to January 2023 | |
Primary | Influence of caloric intake on the development of atopic dermatitis | The researchers will look at the medical history for caloric and macronutrient intake during the first weeks of life and assess whether it is related to differences in the development of atopic dermatitis. | From birth to January 2023 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05018806 -
Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic Dermatitis
|
Phase 2 | |
Completed |
NCT04090229 -
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneously Delivered ASLAN004 in Adults With Moderate-Severe Atopic Dermatitis
|
Phase 1 | |
Terminated |
NCT03847389 -
Clobetasol Topical Oil for Children With Moderate to Severe Atopic Dermatitis
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT05388760 -
Tralokinumab Monotherapy for Children With Moderate-to-severe Atopic Dermatitis - TRAPEDS 1 (TRAlokinumab PEDiatric Trial no. 1)
|
Phase 2 | |
Completed |
NCT05530707 -
Evaluation of Acceptability, Skin Barrier Restoration and Balance of Atopic Skin Using Moisturizer
|
N/A | |
Completed |
NCT02595073 -
Clinical Study to Evaluate the Efficacy and Safety of Desoximetasone (DSXS) With Atopic Dermatitis
|
Phase 3 | |
Recruiting |
NCT05509023 -
Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD)
|
Phase 2 | |
Recruiting |
NCT05048056 -
Phase 2 Study of Efficacy and Safety of AK120, in Subjects With Moderate-to-Severe Atopic Dermatitis
|
Phase 2 | |
Completed |
NCT04598269 -
Study of ATI-1777 in Adult Patients With Moderate or Severe Atopic Dermatitis
|
Phase 2 | |
Recruiting |
NCT03936335 -
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)
|
||
Withdrawn |
NCT03089476 -
Evaluating Skin Barrier Dysfunction in Infants at High Risk of Atopy
|
N/A | |
Recruiting |
NCT05029895 -
A Study to Evaluate Adverse Events and Change in Disease State of Oral Upadacitinib in Adolescent Participants Ages 12 to <18 Years Old Diagnosed With Atopic Dermatitis (AD)
|
||
Terminated |
NCT03654755 -
Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
|
Phase 2 | |
Completed |
NCT04556461 -
Effects of Tralokinumab Treatment of Atopic Dermatitis on Skin Barrier Function
|
Phase 2 | |
Recruiting |
NCT04818138 -
BROadband vs Narrowband photoTherapy for Eczema Trial Nested in the CACTI Cohort
|
N/A | |
Completed |
NCT03719742 -
A Clinical Study to Evaluate the Safety and Efficacy of a Baby Cleanser and a Moisturizer
|
N/A | |
Completed |
NCT05375955 -
A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.
|
Phase 2 | |
Completed |
NCT03441568 -
In-home Use Test of the New Modified Diprobase Formulation to Assess the Safety and Tolerability in Infants and Children Under Physician's Control
|
N/A | |
Recruiting |
NCT06366932 -
Optimization of Atopic Dermatitis Treatment That Requires Second-line Systemic Therapy Through Predictive Models
|
Phase 4 | |
Completed |
NCT03304470 -
A Study to Evaluate the Safety and Efficacy of ATx201 in Subjects With Moderate Atopic Dermatitis
|
Phase 2 |